Other Awards and Honors
2010 Elected Positions and Offices
Darrell Fisher invited member of AREVA Med's High-Level Science Advisory Committee
Darrell Fisher has been named as one of five members of a new, high-level science advisory committee formed by AREVA Med to support rapid development of new radiopharmaceuticals for cancer treatment. AREVA Med LLC is a subsidiary of the French nuclear energy company AREVA. As a specialist in isotope production and medical radiation dosimetry, Darrell will provide strategic advice and scientific guidance for product development and testing leading to regulatory approval of new radioimmunotherapy drug products targeting ovarian and breast cancer. The new drugs employ lead-212/bismuth-212-labeled antibodies. (announced 8/1/2010)